Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Crispr-Cas System: A Promising Diagnostic Tool for Covid-19 Publisher



Ebrahimi S1 ; Khanbabaei H2 ; Abbasi S3 ; Fani M4 ; Soltani S5 ; Zandi M5 ; Najafimemar Z6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology & Virology, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Radiologic Technology, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran
  3. 3. Abadan University of Medical Sciences, Abadan, Iran
  4. 4. Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
  5. 5. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Infectious Diseases Resea rch Center, Golestan University of Medical Sciences, Gorgan, Iran

Source: Avicenna Journal of Medical Biotechnology Published:2022


Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19. © 2022, Avicenna Journal of Medical Biotechnology. All rights reserved.